STEAP3 and colorectal carcinoma: Further studies found that STEAP3-AS1 conferred the upregulation of STEAP3 protein by interacting with YTHDF2 to prevent m6A-mediated degradation of STEAP3 mRNA, thus preserving Fe2+ concentration to activate Wnt/β-catenin and favor CRC progression.